Back to search

Article

Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens

2023-02-01

Abstract excerpt

<title>Abstract</title><p><bold>Purpose:</bold>To evaluate a new class of blood-based biomarkers, anti-frameshift peptide antibodies, for predicting both tumor responses and adverse immune events to immune checkpoint inhibitor (ICI) therapies in advanced lung cancer patients.<bold>Experimental Design:</bold>Serum samples were obtained from 74 lung cancer patients prior to palliative PD-(L)1 therapies with subseque...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9b98db33-b2ed-55d1-9e51-d1835dccf3d5
DOI
10.21203/rs.3.rs-2472861/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigensDOI 10.21203/rs.3.rs-2472861/v1
Select a neighboring publication to make it the new centre.